Evidera
Denise Zou is a Senior Research Scientist at Evidera, where professional contributions have been made since June 2016. Previously, Denise held positions as a Senior Health Economist and Health Economist at Oxford Outcomes / ICON plc from May 2006 to June 2016. Denise began research career as a Researcher at the University of Calgary in 2005. Denise earned a Master's degree in Economics from the University of Alberta between 2003 and 2004.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.